The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Phase II trial of the phosphatidyinositol-3 kinase (PI3K) inhibitor BKM120 in recurrent glioblastoma (GBM).
Patrick Y. Wen
Consultant or Advisory Role - Genentech; Novartis
Honoraria - Genentech; Merck
Research Funding - Boehringer Ingelheim; Genentech/Roche; Merck; Novartis; Sanofi ; Vascular Biogenics
W. K. Alfred Yung
No relevant relationships to disclose
Ingo K. Mellinghoff
No relevant relationships to disclose
Kathleen Lamborn
No relevant relationships to disclose
Shakti Ramkissoon
No relevant relationships to disclose
Timothy Francis Cloughesy
No relevant relationships to disclose
Mikael Rinne
No relevant relationships to disclose
Antonio Marcilio Padula Omuro
Consultant or Advisory Role - Novocure; Roche/Genentech
Lisa Marie DeAngelis
No relevant relationships to disclose
Mark R. Gilbert
Consultant or Advisory Role - EMD Serono; Genentech; Merck; Novartis
Honoraria - EMD Serono; Genentech; Merck; Novartis
Research Funding - Genentech; GlaxoSmithKline; Merck
Andrew S. Chi
No relevant relationships to disclose
Tracy Batchelor
Consultant or Advisory Role - Advanced Medical; Champions Biotechnology; Kyowa Hakko Kirin; Merck; Roche/Genentech; Spectrum Pharmaceuticals
Honoraria - American Society of Hematology; Educational Concepts Group; Oakstone Medical Publishing; Research to Practice; Robert Michael Educational Institute LLC; UpToDate
Research Funding - AstraZeneca; Millennium; Pfizer
Howard Colman
No relevant relationships to disclose
Susan Marina Chang
No relevant relationships to disclose
Cristian Massacesi
Employment or Leadership Position - Novartis
Emmanuelle DiTomaso
Employment or Leadership Position - Novartis
Michael Prados
No relevant relationships to disclose
David A. Reardon
Consultant or Advisory Role - Amgen; EMD Serono; Merck; Novartis; Roche/Genentech
Honoraria - EMD Serono; Merck; Roche/Genentech
Keith L. Ligon
Research Funding - Novartis